• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 - 2015年海洋细菌产生的抗菌化合物

Antibacterial Compounds from Marine Bacteria, 2010-2015.

作者信息

Schinke Claudia, Martins Thamires, Queiroz Sonia C N, Melo Itamar S, Reyes Felix G R

机构信息

Department of Food Science, School of Food Engineering, University of Campinas , Campinas-SP, CEP 13083-862, Brazil.

Brazilian Agricultural Research Corporation , Rodovia SP-340 km 127.5, Jaguariúna-SP, CEP 13820-000, Brazil.

出版信息

J Nat Prod. 2017 Apr 28;80(4):1215-1228. doi: 10.1021/acs.jnatprod.6b00235. Epub 2017 Mar 31.

DOI:10.1021/acs.jnatprod.6b00235
PMID:28362500
Abstract

This review summarizes the reports on antibacterial compounds that have been obtained from marine-derived bacteria during the period 2010-2015. Over 50 active compounds were isolated during this period, most of which (69%) were obtained from Actinobacteria. Several compounds were already known, such as etamycin A (11) and nosiheptide (65), and new experiments with them showed some previously undetected antibacterial activities, highlighting the fact that known natural products may be an important source of new antibacterial leads. New broad-spectrum antibacterial compounds were reported with activity against antibiotic resistant Gram-positive and Gram-negative bacteria. Anthracimycin (33), kocurin (66), gageotetrins A-C (72-74), and gageomacrolactins 1-3 (86-88) are examples of compounds that display promising properties and could be leads to new antibiotics. A number of microbes produced mixtures of metabolites sharing similar chemical scaffolds, and structure-activity relationships are discussed.

摘要

本综述总结了2010年至2015年期间从海洋来源细菌中获得的抗菌化合物的相关报道。在此期间分离出了50多种活性化合物,其中大部分(69%)来自放线菌。一些化合物是已知的,如埃他霉素A(11)和诺西肽(65),对它们进行的新实验显示出一些以前未检测到的抗菌活性,这突出了已知天然产物可能是新抗菌先导物的重要来源这一事实。有报道称发现了新的广谱抗菌化合物,它们对耐抗生素的革兰氏阳性菌和革兰氏阴性菌具有活性。炭疽霉素(33)、科库林(66)、盖奥替菌素A - C(72 - 74)以及盖奥大环内酯1 - 3(86 - 88)都是具有良好特性、有望成为新型抗生素先导物的化合物实例。许多微生物产生了具有相似化学骨架的代谢物混合物,并对其构效关系进行了讨论。

相似文献

1
Antibacterial Compounds from Marine Bacteria, 2010-2015.2010 - 2015年海洋细菌产生的抗菌化合物
J Nat Prod. 2017 Apr 28;80(4):1215-1228. doi: 10.1021/acs.jnatprod.6b00235. Epub 2017 Mar 31.
2
Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete.海洋放线菌来源的强效炭疽抗生素——炭疽霉素。
Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7822-4. doi: 10.1002/anie.201302749. Epub 2013 Jun 17.
3
Lipoxazolidinones A, B, and C: antibacterial 4-oxazolidinones from a marine actinomycete isolated from a Guam marine sediment.脂恶唑烷酮A、B和C:从关岛海洋沉积物中分离出的一种海洋放线菌产生的抗菌4-恶唑烷酮类化合物。
J Nat Prod. 2007 Sep;70(9):1454-7. doi: 10.1021/np0702032. Epub 2007 Sep 11.
4
Secondary Metabolites of Actinomycetes and their Antibacterial, Antifungal and Antiviral Properties.放线菌的次生代谢产物及其抗菌、抗真菌和抗病毒特性
Pol J Microbiol. 2018;67(3):259-272. doi: 10.21307/pjm-2018-048.
5
Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities.来自放线菌的I类羊毛硫抗生素家族及其抗菌活性的改善。
ACS Chem Biol. 2015 Apr 17;10(4):1034-42. doi: 10.1021/cb500878h. Epub 2015 Jan 23.
6
Antibacterial products of marine organisms.海洋生物的抗菌产物。
Appl Microbiol Biotechnol. 2015 May;99(10):4145-73. doi: 10.1007/s00253-015-6553-x. Epub 2015 Apr 15.
7
Novel cajaninstilbene acid derivatives as antibacterial agents.新型 cajaninstilbene 酸衍生物作为抗菌剂。
Eur J Med Chem. 2015 Jul 15;100:235-45. doi: 10.1016/j.ejmech.2015.06.008. Epub 2015 Jun 10.
8
[The history of the development and changes of quinolone antibacterial agents].[喹诺酮类抗菌药物的发展与变迁史]
Yakushigaku Zasshi. 2003;38(2):161-79.
9
Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens.海洋来源细菌的次生代谢产物具有抗耐药病原菌的抗生素和抗生物膜活性。
Mar Drugs. 2023 Jan 12;21(1):50. doi: 10.3390/md21010050.
10
Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete.来那霉素A - E,一类源自新型海洋放线菌的氯化双吲哚吡咯抗生素。
J Nat Prod. 2008 Oct;71(10):1732-7. doi: 10.1021/np800286d. Epub 2008 Oct 9.

引用本文的文献

1
Novel 3D-Printed Replica Plate Device Ensures High-Throughput Antibacterial Screening of Halophilic Bacteria.新型3D打印复制平板装置确保对嗜盐细菌进行高通量抗菌筛选。
Mar Drugs. 2025 Jul 23;23(8):295. doi: 10.3390/md23080295.
2
Virtual screening and molecular dynamic simulations of dissimilatory sulfite reductase inhibitors for the control of sulphate reducing bacteria.用于控制硫酸盐还原菌的异化亚硫酸盐还原酶抑制剂的虚拟筛选和分子动力学模拟
In Silico Pharmacol. 2025 Jun 17;13(2):90. doi: 10.1007/s40203-025-00367-9. eCollection 2025.
3
A Mini-Review of Anti-Listerial Compounds from Marine Actinobacteria (1990-2023).
海洋放线菌抗李斯特菌化合物的综述(1990 - 2023年)
Antibiotics (Basel). 2024 Apr 15;13(4):362. doi: 10.3390/antibiotics13040362.
4
Synthesis of Benzofuro[3,2-]indol-3-one Derivatives via Dearomative (3 + 2) Cycloaddition of 2-Nitrobenzofurans and -Quinamines.通过2-硝基苯并呋喃与喹哪啶的去芳构化(3 + 2)环加成反应合成苯并呋喃[3,2-]吲哚-3-酮衍生物
Molecules. 2024 Mar 5;29(5):1163. doi: 10.3390/molecules29051163.
5
Bioprospecting of unexplored halophilic actinobacteria against human infectious pathogens.未开发的嗜盐放线菌针对人类传染性病原体的生物勘探。
3 Biotech. 2023 Dec;13(12):398. doi: 10.1007/s13205-023-03812-8. Epub 2023 Nov 14.
6
Rapid Unambiguous Structure Elucidation of Streptnatamide A, a New Cyclic Peptide Isolated from A Marine-derived Streptomyces sp.快速明确解析海洋来源链霉菌 Streptnatamide A 的结构,这是一种新型环肽。
Chemistry. 2023 Oct 9;29(56):e202301813. doi: 10.1002/chem.202301813. Epub 2023 Sep 6.
7
Iseoic acids and bisiseoate: three new naphthohydroquinone/naphthoquinone-class metabolites from a coral-derived Streptomyces.异海松酸和双异海松酸:珊瑚源链霉菌中三种新的萘氢醌/萘醌类代谢物。
J Antibiot (Tokyo). 2023 Oct;76(10):618-622. doi: 10.1038/s41429-023-00644-9. Epub 2023 Jul 11.
8
Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens.海洋来源细菌的次生代谢产物具有抗耐药病原菌的抗生素和抗生物膜活性。
Mar Drugs. 2023 Jan 12;21(1):50. doi: 10.3390/md21010050.
9
Bioprospecting for Novel Bacterial Sources of Hydrolytic Enzymes and Antimicrobials in the Romanian Littoral Zone of the Black Sea.在黑海罗马尼亚滨海地区探寻新型水解酶和抗菌剂细菌来源的生物勘探
Microorganisms. 2022 Dec 14;10(12):2468. doi: 10.3390/microorganisms10122468.
10
Selective isolation of Arctic marine actinobacteria and a down-scaled fermentation and extraction strategy for identifying bioactive compounds.北极海洋放线菌的选择性分离及用于鉴定生物活性化合物的小型发酵和提取策略。
Front Microbiol. 2022 Nov 21;13:1005625. doi: 10.3389/fmicb.2022.1005625. eCollection 2022.